Optum Company, which is part of UnitedHealth Group (UNH), to grow in size with the acquisition of Surgical Care Affiliates (SCAI).
Under the terms of the agreement, SCAI shares will be purchased for $ 57 / share, which implies a 17% premium to Friday's closing price, and the purchase will be financed through a combination of cash and shares. In particular, from 51% to 80% of the purchase price will be financed by UNH ordinary shares, while the remaining part will be paid in cash. UnitedHealth Group have the opportunity later to determine what portion of the transaction will be paid in shares.
The transaction is expected to be completed during the first half of 2017. UnitedHealth Group estimates that the purchase will have a neutral impact on its adjusted net earnings per share in 2017 and light in 2018.
UNH shares fell in premarket trading to $ 161.58 (-0.51%).
© 2000-2024. All rights reserved.
This site is managed by Teletrade D.J. LLC 2351 LLC 2022 (Euro House, Richmond Hill Road, Kingstown, VC0100, St. Vincent and the Grenadines).
The information on this website is for informational purposes only and does not constitute any investment advice.
The company does not serve or provide services to customers who are residents of the US, Canada, Iran, The Democratic People's Republic of Korea, Yemen and FATF blacklisted countries.
Making transactions on financial markets with marginal financial instruments opens up wide possibilities and allows investors who are willing to take risks to earn high profits, carrying a potentially high risk of losses at the same time. Therefore you should responsibly approach the issue of choosing the appropriate investment strategy, taking the available resources into account, before starting trading.
Use of the information: full or partial use of materials from this website must always be referenced to TeleTrade as the source of information. Use of the materials on the Internet must be accompanied by a hyperlink to teletrade.org. Automatic import of materials and information from this website is prohibited.
Please contact our PR department if you have any questions or need assistance at pr@teletrade.global.